PATENT CLAIM ANALYSIS

Application Number: 15765317
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["536", "024500"]

Abstract:
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IXβ reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.

Claim (Index 3):
The method of  claim 1 , wherein the BLVRB enzymatic activity is inhibited by at least about 30% to about 100%.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.28571
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14515619', '14138008', '14534394', '14650685', '13881587']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.601659030153887
- 35 USC 102 Novelty (BERT): 0.5196995213513173
- Combined Prediction Score: 0.59346307927363
- Mean Citation Score: 186.45257
- Max Citation Score: 200.9485
- Similarity Product: 90.43153573657573

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test